APA (7th ed.) Citation

SA, A., A, R., AKMH, M., T, P., TN, S., Y, N., . . . S, H. (2025). Extraction and dual-phase optimization of anticancer doses of selective novel flavonoids from yangmei (Myrica rubra) in CRISPR-KO TRα cell lines of PTC: Insights into Traditional Chinese Medicine for targeted therapeutic manufacturing. 3 Biotech, 15(10), 365. https://doi.org/10.1007/s13205-025-04543-8

Chicago Style (17th ed.) Citation

SA, Azad, et al. "Extraction and Dual-phase Optimization of Anticancer Doses of Selective Novel Flavonoids from Yangmei (Myrica Rubra) in CRISPR-KO TRα Cell Lines of PTC: Insights into Traditional Chinese Medicine for Targeted Therapeutic Manufacturing." 3 Biotech 15, no. 10 (2025): 365. https://doi.org/10.1007/s13205-025-04543-8.

MLA (9th ed.) Citation

SA, Azad, et al. "Extraction and Dual-phase Optimization of Anticancer Doses of Selective Novel Flavonoids from Yangmei (Myrica Rubra) in CRISPR-KO TRα Cell Lines of PTC: Insights into Traditional Chinese Medicine for Targeted Therapeutic Manufacturing." 3 Biotech, vol. 15, no. 10, 2025, p. 365, https://doi.org/10.1007/s13205-025-04543-8.